Communication, Diabetes and Magazine

SCHOTT Pharma invests in RTU cartridge capacity expansion

Pharmaceutical Technology

JUNE 6, 2025

Find out more RTU cartridges are essential for storing glucagon-like peptide-1 drugs, biologics, insulin and hormone therapies used for treating diabetes, obesity and other immunological conditions. Can pharma tariffs “Make America Manufacture Again”? It will further extend the site’s manufacturing capabilities for high-value solutions.

Health and Personal Care Stores

Health and Personal Care Stores Communication Diabetes Hospitals

Genomics to roll out predictive clinical test across UK

Pharmaceutical Technology

JUNE 18, 2025

The full UK test will also look at a person’s susceptibility to developing type 2 diabetes, prostate cancer and breast cancer. Can pharma tariffs “Make America Manufacture Again”? The test was also evaluated in a clinical trial conducted with the NHS to evaluate its ability to detect signs of cardiovascular disease.

Communication

Communication Hospitals Packaging Diabetes

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

JUNE 23, 2025

Eylea is approved in four indications in Europe: the treatment of ‘wet’ age-related macular degeneration (AMD), visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV).

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

JULY 4, 2025

This will largely be driven by the company’s glucagon like peptide-1 receptor agonist (GLP-1RA) tirzepatide, sold under the brand names Mounjaro and Zepbound for weight loss and type 2 diabetes respectively. Give your business an edge with our leading industry insights.

Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs

Pharmaceutical Technology

JUNE 12, 2025

The drugmaker’s flagship drug semaglutide, known under the brand names Wegovy and Ozempic for obesity and type 2 diabetes treatment respectively, targets the glucagon-like peptide-1 receptor (GLP-1R), a key component of the incretin system. Can pharma tariffs “Make America Manufacture Again”?

Diabetes

Diabetes Compounding Communication Hospitals

Makary: Drugs don’t have to take 10 years to get to market

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Pharmaceutical Technology

JUNE 18, 2025

Find out more Fleischer said that the programme will provide more services for patients receiving its glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide, which is marketed as Wegovy for weight loss and Ozempic in type 2 diabetes, including fitness and dietary advice. Can pharma tariffs “Make America Manufacture Again”?

Communication

Communication Hospitals Packaging Compounding

From data to impact: How real-world evidence will transform healthcare

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Pharmaceutical Companies Pharmaceutical Companies

Barriers are limiting UK childhood vaccination, say doctors

pharmaphorum

JULY 1, 2025

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies

Why security-first design is the fix to stalling AI pilot tools

pharmaphorum

JULY 2, 2025

Skip to main content Wednesday 2 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Development

Bridging the gap: A comprehensive approach to social determinants of health

Pharmaceutical Technology

JUNE 23, 2025

SDoH can influence diabetes risk and management, and access to healthcare can also affect disease management and progression. One study dove into whether annual income influenced choice in GLP-1 RA therapy for patients with Type 2 Diabetes. Can pharma tariffs “Make America Manufacture Again”? Sign up for our daily news round-up!

Insurance Coverage and Processing

Insurance Coverage and Processing Diabetes Pharmaceutical Manufacturing Communication

207 community hospital presidents and CEOs to know | 2025

Beckers Hospital Review

JULY 11, 2025

She joined the organization over 30 years ago and worked alongside providers and staff to drive improvements in patient care, culture and communication. Her calm, hands-on leadership during the Covid-19 pandemic earned widespread respect, guiding the hospital and community through uncertainty with clear communication and unwavering presence.

Hospitals

Hospitals Inpatient Communication Nursing Homes

Network With EHS Professionals - EHS&S for Biopharma West

pharmaphorum

JULY 9, 2025

Skip to main content Wednesday 9 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Communication

Welcome to the 2nd Raw Materials for Cell & Gene Therapy Summit!

pharmaphorum

JULY 9, 2025

Skip to main content Wednesday 9 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

How the patient voice is becoming vital for drug approval

pharmaphorum

JUNE 14, 2021

This article appears in our free digital magazine Deep Dive: Market Access 2021. This can lead to metabolic abnormalities including insulin resistance, diabetes, and elevated levels of blood lipids (such as high cholesterol). Read below for a preview! . Fighting for access.

Communication

Communication Diabetes

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

pharmaphorum

NOVEMBER 1, 2022

When Plaid effectively forced financial institutions to take an open-protocol approach to digital interoperability, “Every bank (took) their five-year strategy on digitizing and brought it down into one or two years,” CEO Zach Perret said in an interview with Fortune magazine. The time to cross that bridge has passed. About the author.

HIPAA

HIPAA Insurance Coverage and Processing Specialty Pharmacies Communication

Innovative Healthcare Advertising Strategies: Transforming Pharma Marketing in the Digital Era

Pharma Marketing Network

DECEMBER 13, 2024

Patient-Centric Approaches: The shift towards patient empowerment has revolutionized the way pharma brands communicate. Television and Print: While digital is dominant, TV and magazines still play a role, especially for older audiences. Campaigns now prioritize storytelling and empathy. Patient Stories: Share real-life success stories.

Dosage

Dosage Communication Diabetes

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): That is really really cool and I think a relief to millions of diabetes sufferers probably around the world as one of the most extensive diseases. Robin (Guest): Just like any of the other like wearable track right it’s. Don ( PMN): Sure. Robin (Guest): And have Bluetooth-enabled and all of that. Robin (Guest): Absolutely.

Hospitals

Hospitals Packaging Communication Diabetes

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): That is really really cool and I think a relief to millions of diabetes sufferers probably around the world as one of the most extensive diseases. Robin (Guest): Just like any of the other like wearable track right it’s. Don ( PMN): Sure. Robin (Guest): And have Bluetooth-enabled and all of that. Robin (Guest): Absolutely.

Hospitals

Hospitals Packaging Communication Diabetes

Building honest dialogue with patient advocates

pharmaphorum

JUNE 22, 2021

Blogger Chris Aldred and Joe Delahunty from Ascensia Diabetes Care have been working together to answer that question for five years. This article appears in our free digital magazine Deep Dive: Market Access 2021. I think everyone in the diabetes community advocates for something because they’re passionate about it. “I

Diabetes

Diabetes Communication

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

JUNE 11, 2020

They were the first that the first Facebook Page that was a product page, I believe, or a diabetes that was maybe a diabetes page. And now it’s a common communication channel even for the President. He was the Novo Nordisk spokesperson for an overlock Flex Pen it was for diabetes. It was US and UK.

Communication

Communication Pharmaceutical Companies Pharmaceutical Companies Diabetes

Emotional empathy is driving brand equity

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. In Britain, the venerable BBC launched BBC Bitesize to help parents home-school children.

Health and Personal Care Stores

Health and Personal Care Stores Vaccines Communication Diabetes

Pharmacist Digest

SCHOTT Pharma invests in RTU cartridge capacity expansion

Genomics to roll out predictive clinical test across UK

Trending Sources

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Big pharma braces for revenue headwinds as patent expiries loom

Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs

Makary: Drugs don’t have to take 10 years to get to market

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

From data to impact: How real-world evidence will transform healthcare

Barriers are limiting UK childhood vaccination, say doctors

Why security-first design is the fix to stalling AI pilot tools

Bridging the gap: A comprehensive approach to social determinants of health

207 community hospital presidents and CEOs to know | 2025

Network With EHS Professionals - EHS&S for Biopharma West

Welcome to the 2nd Raw Materials for Cell & Gene Therapy Summit!

How the patient voice is becoming vital for drug approval

Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

Innovative Healthcare Advertising Strategies: Transforming Pharma Marketing in the Digital Era

Pharma Marketing Network - Untitled Article

Pharma Marketing Network - Untitled Article

Building honest dialogue with patient advocates

Ep. 001 – John Mack Podcast Transcript

Emotional empathy is driving brand equity

Stay Connected